photonamic GmbH & Co. KG

MolecuLight specializes in innovative imaging solutions for wound care, particularly in the detection of harmful bacteria and the measurement of wounds. The company develops portable handheld optical imaging devices that allow medical practitioners to visualize bacteria and assess tissue viability at the point of care. These devices facilitate the documentation and monitoring of wound healing progress, enabling healthcare professionals to select the appropriate therapy for their patients in a timely manner. By providing accurate analysis and procedural guidance, MolecuLight's technology aims to enhance patient outcomes in wound management.

NX Development Corp. is a life sciences company based in Lexington, Kentucky, focused on developing innovative solutions for neurosurgery. Incorporated in 2010, the company specializes in Gleolan (Aminolevulinic Acid Hydrochloride), an optical imaging agent designed to assist in the visualization of malignant tissue during surgery for patients with glioma. This product enhances the precision and extent of tumor resection while remaining cost-effective for hospitals and insurers, without adding new medical risks. As a subsidiary of photonamic GmbH & Co. KG, NX Development Corp. aims to support neurosurgeons by integrating Gleolan with existing fluorescence add-on kits from leading surgical microscope manufacturers, thereby improving surgical outcomes in the treatment of Glioblastoma.